Sign in

CIK 0001817713

  • Large accelerated filer

Janux Therapeutics, Inc.

Sign in to watch
Ticker
JANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
822289112
Phone
+1 858-751-4493
Business address
10955 VISTA SORRENTO PARKWAY, SUITE 200, SAN DIEGO, CA, 92130
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-06-11 Gujrathi Sheila Director Grant or award · Stock Option (right to buy) +11,667 11,667
2025-06-11 Hernday Natasha Director Grant or award +3,750 8,731
2025-06-11 Hernday Natasha Director Grant or award · Stock Option (right to buy) +11,667 11,667
2025-06-11 McNulty Alana B. Director Grant or award +3,750 6,250
2025-06-11 McNulty Alana B. Director Grant or award · Stock Option (right to buy) +11,667 11,667
2025-06-11 Simson Jake Director Grant or award +3,750 6,250
2025-06-11 Simson Jake Director Grant or award · Stock Option (right to buy) +11,667 11,667
2025-06-11 Kung Winston Director Grant or award +3,750 6,250
2025-06-11 Kung Winston Director Grant or award · Stock Option (right to buy) +11,667 11,667
2025-06-02 Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr Grant or award +44,000 44,000
2025-06-02 Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr Grant or award · Stock option (right to buy) +154,000 154,000
2025-05-01 Meyer Andrew Hollman Chief Business Officer Option exercise 10b5-1 +3,333 $4.21 $14K 85,472
2025-05-01 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −2,933 $31.95 $94K 82,539
2025-05-01 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −400 $32.60 $13K 82,139
2025-05-01 Meyer Andrew Hollman Chief Business Officer Option exercise · Stock Option (right to buy) 10b5-1 −3,333 87,332
2025-04-21 Meyer Andrew Hollman Chief Business Officer Option exercise 10b5-1 +3,334 $4.21 $14K 85,473
2025-04-21 Meyer Andrew Hollman Chief Business Officer Sale 10b5-1 −3,334 $30.00 $100K 82,139
2025-04-21 Meyer Andrew Hollman Chief Business Officer Option exercise · Stock Option (right to buy) 10b5-1 −3,334 90,665
2025-03-07 RA CAPITAL MANAGEMENT, L.P. Director Purchase +110,206 $31.02 $3.4M 10,141,287
2025-03-06 RA CAPITAL MANAGEMENT, L.P. Director Purchase +372,093 $30.78 $11.5M 10,031,081

Page 4 of 15 · 294 trades